Search

Search Constraints

You searched for: Author/Creator O'Brien, Christopher D.

Search Results

1. A Randomized, Placebo-Controlled Phase 2 Trial of CNTO 6785 in Chronic Obstructive Pulmonary Disease. (3rd September 2017)

4. Impact of Response and Inflammatory Burden at Start of Maintenance Therapy on Clinical Efficacy of Ustekinumab Dosing Regimen in UC: Week 44 Results From UNIFI: 842. (October 2019)

5. Safety of Ustekinumab in Inflammatory Bowel Diseases: Integrated Safety Analysis of Results From Phase 2 and 3 Studies in Crohn's Disease and Ulcerative Colitis: 697. (October 2019)

6. Ustekinumab is effective and safe for ulcerative colitis through 2 years of maintenance therapy. Issue 11 (21st October 2020)